Drug Shortage Report for MYLAN-MONTELUKAST
Report ID | 7052 |
Drug Identification Number | 02380749 |
Brand name | MYLAN-MONTELUKAST |
Common or Proper name | MONTELUKAST |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MONTELUKAST |
Strength(s) | 4MG |
Dosage form(s) | TABLET (CHEWABLE) |
Route of administration | ORAL |
Packaging size | 30BL |
ATC code | R03DC |
ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-04-11 |
Estimated end date | |
Actual end date | 2017-09-07 |
Shortage status | Resolved |
Updated date | 2017-09-08 |
Company comments | Discontinuation reported under ID 16138. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-04-13 | English | Compare |
v2 | 2017-04-13 | French | Compare |
v3 | 2017-09-08 | English | Compare |
v4 | 2017-09-08 | French | Compare |
Showing 1 to 4 of 4